Fingolimod 0.5mg

Carboplatin is a chemotherapy medication used to treat a number of forms of cancer. This includes ovarian cancer, lung cancer, head and neck cancer, brain cancer, and neuroblastoma.[1] It is used by injection into a vein.

Cisplatin is a chemotherapy medication used to treat a number of cancers. These include testicular cancer, ovarian cancer, cervical cancer, breast cancer, bladder cancer, head and neck cancer, esophageal cancer, lung cancer, mesothelioma,&nbs...

Clofarabine is a purine nucleoside antimetabolite 

Abiraterone Acetate is a medication used to treat prostate cancer. Specifically it is used together with a corticosteroid for metastatic castration-resistant prostate cancer and metastatic high-risk castration-sensitive prostate cancer

Megastrol Acetate Its acylated derivative megestrol acetate is also a progestogen, which, in contrast to megestrol itself, has been extensively used as a pharmaceutical drug.

Decitabine acts as a nucleic acid synthesis inhibitor. It is a medication for the treatment of myelodysplastic syndromes, a class of conditions where certain blood cells are dysfunctional, and for acute myeloid leukemia. Chemically, it is a cytidine analog.

Icatibant is a medication for the symptomatic treatment of acute attacks of hereditary angioedema in adults with C1-esterase-inhibitor deficiency.

Imatinib is an oral chemotherapy medication used to treat cancer.

Lenalidomide is a medication used to treat multiple myeloma and myelodysplastic syndromes. For MM it is used after at least one other treatment and generally together with dexamethasone.

Methotrexate is a chemotherapy agent and immune-system suppressant. It is used to treat cancer, autoimmune diseases, and ectopic pregnancy and for medical abortions

Methotrexateis a chemotherapy agent and immune-system suppressant. It is used to treat cancer, autoimmune diseases, and ectopic pregnancy and for medical abortions

mitomycin that is used as a chemotherapeutic agent by virtue of its antitumour activity. It is given intravenously to treat upper gastro-intestinal cancers, anal cancers, and breast cancers, as well as by bladder instillation for superficial bladder tumours

 

Onko Koçsel is proud that Bortezomib Injection 3.5 mg vial DCP application has been successfully accepted by EMA member countries on March, 2021. Onko Koçsel is open for collaboration within and outside EU countries.

Onko Kocsel Factory video